How do doctors treat ALK-rearranged lung cancer? 

Learn more about lung cancer at www.YouAndLungC...
Medical oncologist Dr. Joseph Leach provides an overview of how doctors treat ALK-rearranged lung cancer. He discusses targeted therapies for ALK mutations including alectinib, brigatinib, and lorlatinib, which are effective in controlling cancer. He explains that cancer cells can become resistant to targeted therapies, so it is important to repeat biomarker testing if treatment stops working at any time and to also consider participating in clinical trials.